UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000001142
Receipt No. R000001386
Scientific Title Phase I Study of gemtuzumab ozogamicin in combination with cytarabinne and idarubicin as induction therapy for relapsed or refractory patients with acute myeloid leukemia.
Date of disclosure of the study information 2008/05/10
Last modified on 2011/10/31 16:03:29

No. Disposal Last modified on Item of update
1 Insert 2008/04/30 19:07:32
2 Update 2009/10/30 15:48:03 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
3 Update 2010/05/14 18:26:02 Date analysis concluded
4 Update 2011/10/31 16:03:29 Recruitment status
Date analysis concluded
Publication of results
URL related to results and publications
Results
Results


Contact us.